Stephen Knight, MBA, MD
Stephen Knight, MD, serves as President and Managing Partner of F-Prime Capital. He has worked in the pharmaceutical and biotechnology industries for over 25 years and invests broadly across healthcare.
Prior to joining F-Prime Capital, Steve held various senior management roles in private and public biotechnology and consulting companies. He was also a researcher at AT&T Bell Laboratories, the National Institutes of Health, and Yale University. In addition to Sana Biotechnology, Steve serves on the Board of Directors of Beam Therapeutics, Geneception, Genomics plc, Innovent Biologics, Iora Health, and Pulmocide.
He holds an MD from the Yale University School of Medicine, an MBA from the Yale School of Organization and Management, and a BS in biology from Columbia University, graduating summa cum laude and Phi Beta Kappa.